teclistamab
genmab,janssen
['multiple myeloma', 'teclistamab', 'janssen', '$jnj']
johnson &amp; johnson's janssen announced updated data for bispecific teclistamab suggest continued deep and durable responses in the treatment of patients with relapsed or refractory multiple myeloma; data presented at asco $jnj 
Stock Ideas, Option Sweeps, Low Float Breakouts, Momentum alerts
?? Get Early Access to the best trading community https://t.co/I9XMXtHZX3
https://t.co/G1K6KOlXMJ